- €8.60bn
- €8.49bn
- €4.07bn
Brief: Biomerieux Gets FDA Special 510(K) Clearance For Biofire Spotfire Respiratory/Sore Throat Panel Mini
Brief: Biomerieux Receives U.S. FDA Clearance For Its Ast System Vitek Reveal
Brief: Biomerieux Receives FDA 510(K) Clearance Of VIDAS TBI
Brief: Malawi Health Ministry, bioMerieux, Pfizer Form Multisectoral Collaboration On Antimicrobial Resistance
Barclays starts Biomerieux at 'overweight,' notes smoother growth among peers
Barclays cites DiaSorin's in-line top-line but 'ambitious' margins - starts at 'equal weight'
Europe Research Roundup: Arkema, Fuller Smith & Turner, Siemens Energy
Top of the Street: Galp, Reckitt, Legrand, Biomerieux
Europe Research Roundup: Adriatic Metals, Diageo, GB Group
Europe Research Roundup: Bytes Technology, Marks and Spencer, Phoenix
Europe Research Roundup: Alfen, Boliden, Pennon Group
Brief: Sitam Belgique Completes The Disposal Of 0.8% Of Biomerieux
Slide in defence stocks knocks down Europe's STOXX 600 (updated)
Biomerieux shares eye best day in 25 mths after better-than-expected Q1
Live Markets: European shares off to a gloomy start
Brief: Biomerieux Aims At Organic Revenue Growth Of +7% CAGR 2024-2028
Brief: Biomerieux Q1 Consolidated Sales Up 6.6% At EUR 965 Million
Brief: Biomerieux, Merieux Nutrisciences Partner With Food Industry Players
Advisory: Dated alerts on Biomerieux results withdrawn